Saffron-based crocin prevents liver cancer: Preclinical studies and beyond
Biomolecule of the golden spice is good for your liver
- Date:
- January 4, 2016
- Source:
- Bentham Science Publishers
- Summary:
- Liver cancer remains among the leading causes of cancer-related death worldwide. Now new research unravels mechanisms by which saffron-based 'crocin' protects against liver cancer.
- Share:
Liver cancer remains among the leading causes of cancer-related death worldwide. New study lead by UAE University Prof. Amr Amin unravels mechanisms by which saffron-based 'crocin' protects against liver cancer.
The study entitled 'Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In Vivo, In Vitro and Network Analyses' is funded by Al-Jalila Foundation & Terry Fox Foundation and is published in Recent Patents on Anticancer Drug Discovery.
Using murine model, human liver cancer cells, gene expression profiling and computer-assisted modeling analyses, Amin's study identifies NF-kB as a regulatory hub and a candidate therapeutic drug target for liver cancer.
Story Source:
Materials provided by Bentham Science Publishers. Note: Content may be edited for style and length.
Journal Reference:
- Amr Amin, Alaaeldin A. Hamza, Sayel Daoud, Kamal Khazanehdari, Ala`a Al Hrout, Baig Ala`a, Amphun Chaiboonchoe, Thomas E. Adrian, Kourosh Zaki. Saffron-Based Crocin Prevents Early Lesions of Liver Cancer: In Vivo, In Vitro and Network Analyses. Recent Patents on Anti-Cancer Drug Discovery, 2015; 10 (999): 1 DOI: 10.2174/1574892810666151102110248
Cite This Page: